Report overview
Fluorescence in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes that bind to only those parts of a nucleic acid sequence with a high degree of sequence complementarity.
This report contains market size and forecasts of Fluorescence In Situ Hybridization Probe in Global, including the following market information:
Global Fluorescence In Situ Hybridization Probe Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fluorescence In Situ Hybridization Probe market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fluorescence In Situ Hybridization Probe include PerkinElmer, Roche, Abnova Corporation, LGC Biosearch Technologies, Abbott Laboratories, Agilent Technologies, Genemed Biotechnologies, Oxford Gene Technologies and Life Science Technologies and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fluorescence In Situ Hybridization Probe companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fluorescence In Situ Hybridization Probe Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fluorescence In Situ Hybridization Probe Market Segment Percentages, by Type, 2021 (%)
DNA
RNA
Global Fluorescence In Situ Hybridization Probe Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fluorescence In Situ Hybridization Probe Market Segment Percentages, by Application, 2021 (%)
Laboratory
Research Institutions
Others
Global Fluorescence In Situ Hybridization Probe Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fluorescence In Situ Hybridization Probe Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fluorescence In Situ Hybridization Probe revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fluorescence In Situ Hybridization Probe revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PerkinElmer
Roche
Abnova Corporation
LGC Biosearch Technologies
Abbott Laboratories
Agilent Technologies
Genemed Biotechnologies
Oxford Gene Technologies
Life Science Technologies
Biocare Medical
